portrait

LinguaDiligence

Hong Kong, Hong Kong

Translate From: English (EN)

Translate To: French (FR)

276

Words Translated

38

Terms Translated

LinguaDiligence’s Selected Translation Work

Terms and text shown below represent LinguaDiligence’s contributions to TermWiki.com, a free terminology website and knowledge resource for the translation community.

stdClass::__set_state(array( 'id' => '6227764', 'url' => 'FR/sponsor_investigator', 'image' => '', 'title' => 'Sponsor-investigateur', 'tags' => array ( 0 => 'Sponsor-investigateur', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Sponsor-investigateur', 'source_id' => 4010894, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150722105912', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'La personne qui initie et conduit l\'étude clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851745107968, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'The person who both initiates and conducts the clinical study.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'sponsor investigator', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'sponsor_investigator', ))

English (EN)sponsor investigator

The person who both initiates and conducts the clinical study.

French (FR)Sponsor-investigateur

La personne qui initie et conduit l'étude clinique.

Medical devices; Clinical trials
stdClass::__set_state(array( 'id' => '7745839', 'url' => 'FR/investigational_treatment', 'image' => '', 'title' => 'Traitement expérimental', 'tags' => array ( 0 => 'Traitement expérimental', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Traitement expérimental', 'source_id' => 1259723, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20150721084114', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Le nouveau médicament ou thérapie testé dans l\'essai clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507294573052821506, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'investigational treatment', 'Definition' => 'The new drug or therapy being tested in the clinical trial.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Synonym' => 'experimental_treatment', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Creation User' => 'John Martin', 'Creation Date' => '2011/5/16', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'investigational_treatment', ))

English (EN)investigational treatment

The new drug or therapy being tested in the clinical trial.

French (FR)Traitement expérimental

Le nouveau médicament ou thérapie testé dans l'essai clinique.

Pharmaceutical; Clinical trials
stdClass::__set_state(array( 'id' => '3951178', 'url' => 'FR/superbug', 'image' => 'Superbug.jpg;', 'title' => 'Superbactéries', 'tags' => array ( 0 => 'Superbactéries', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Superbactéries', 'source_id' => 275134, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20150721084102', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Bactéries résistantes à presque tous les antibiotiques. Les gènes peuvent être transférés entre les bactéries par conjugaison, transduction ou transformation. Cela signifie que les gènes de résistance aux antibiotiques peuvent se lier à de nombreux types de germes courants et leur confèrent une importante résistance aux médicaments, en créant de superbactéries dangereuses. La dernière épidémie de superbactéries implique des patients qui ont voyagé en Inde où il y a une surpopulation et un usage excessif établi des antibiotiques. Beaucoup de gens en Inde manquent également d\'eau potable et ont des diarrhées répandues ; ce sont des conditions idéales pour la création de superbactéries.', 'usage_comment' => '', 'glossary' => '', 'width' => 450, 'height' => 362, '_version_' => 1507294573051772929, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'superbug', 'Definition' => 'Bacteria resistant to nearly all antibiotics. Genes can be transferred between bacteria by conjugation, transduction, or transformation. This means antibiotic resistance genes can hitch onto many types of common germs and confers broad drug resistance, creating dangerous superbugs. The latest outbreak of superbugs involve patients who have travel to India with an overpopulation and documented overuses antibiotics. Many people in India also lack clean water and have widespread diarrhea disease, which are ideal conditions for the creation of the superbug', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Synonym' => 'super bacteria_₀; super bug_₀', 'Sample Image' => 'Superbug.jpg;', 'Industry' => 'Pharmaceutical', 'Domain' => 'Documentation; Marketing', 'Other Reference' => 'TIN', 'Creation User' => 'Bethsm', 'Creation Date' => '2010/9/14', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'superbug', ))

English (EN)superbug

Bacteria resistant to nearly all antibiotics. Genes can be transferred between bacteria by conjugation, transduction, or transformation. This means antibiotic resistance genes can hitch onto many types of common germs and confers broad drug resistance, ...

French (FR)Superbactéries

Bactéries résistantes à presque tous les antibiotiques. Les gènes peuvent être transférés entre les bactéries par conjugaison, transduction ou transformation. Cela signifie que les gènes de résistance aux antibiotiques peuvent se lier à de nombreux types de ...

Pharmaceutical;
stdClass::__set_state(array( 'id' => '2315639', 'url' => 'FR/spirulina_₁', 'image' => 'espirulina-3.jpg', 'title' => 'Spiruline', 'tags' => array ( 0 => 'Spiruline', 1 => 'Pharmaceutical', 2 => 'Healthcare supplement', 3 => '', ), 'term' => 'Spiruline', 'source_id' => 1658962, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Healthcare supplement', ), 'lastedit' => '20150721112809', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'La spiruline est une bactérie bleu-vert du groupe des cyanobactéries ayant une forte valeur nutritionnelle : elle contient des protéines et de la vitamine B12. Les compléments alimentaires sont composés de deux espèces de spiruline : Arthrospira platensis et Arthrospira maxima. Elle est devenue populaire en tant que complément alimentaire à la fin du XXe siècle.', 'usage_comment' => '', 'glossary' => '', 'width' => 250, 'height' => 280, '_version_' => 1507305079939530752, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'spirulina', 'Definition' => 'Spirulina is a green-blue bacterium of the Cyanobacteria group of a high nutritional value: it contains proteins and B12 vitamin. The nutritional supplements are made of two species of spirulina: Arthrospira platensis and Arthrospira maxima. It became popular as a nutritional supplement at the end of the XX century.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Healthcare supplement', 'Creation User' => 'esb', 'Creation Date' => '2011/10/6', 'Sample Image' => 'espirulina-3.jpg', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'spirulina_₁', ))

English (EN)spirulina

Spirulina is a green-blue bacterium of the Cyanobacteria group of a high nutritional value: it contains proteins and B12 vitamin. The nutritional supplements are made of two species of spirulina: Arthrospira platensis and Arthrospira maxima. It became popular ...

French (FR)Spiruline

La spiruline est une bactérie bleu-vert du groupe des cyanobactéries ayant une forte valeur nutritionnelle : elle contient des protéines et de la vitamine B12. Les compléments alimentaires sont composés de deux espèces de spiruline : Arthrospira platensis et ...

Pharmaceutical; Healthcare supplement
stdClass::__set_state(array( 'id' => '6227397', 'url' => 'FR/exclusion_criteria_₁', 'image' => '', 'title' => 'Critères d\'exclusion', 'tags' => array ( 0 => 'Critères d\'exclusion', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Critères d\'exclusion', 'source_id' => 4010892, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150722105910', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Les facteurs ou les raisons qui empêchent une personne de participer à une étude clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851744059394, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'The factors or reasons that prevent a person from participating in a clinical study.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'exclusion criteria', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'exclusion_criteria_₁', ))

English (EN)exclusion criteria

The factors or reasons that prevent a person from participating in a clinical study.

French (FR)Critères d'exclusion

Les facteurs ou les raisons qui empêchent une personne de participer à une étude clinique.

Medical devices; Clinical trials
stdClass::__set_state(array( 'id' => '7745836', 'url' => 'FR/informed_consent_₇', 'image' => '', 'title' => 'Consentement éclairé', 'tags' => array ( 0 => 'Consentement éclairé', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Consentement éclairé', 'source_id' => 1259720, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20150721084111', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un processus afin de s\'assurer que les patients volontaires comprennent tous les risques associés à la participation à un essai clinique tels que les effets indésirables et choisissent de participer sans coercition ni pression de quiconque. Le chercheur principal ou de ses associés sont tenus d\'expliquer l\'étude attentivement et répondre à toutes les questions d\'un participant avant l\'essai clinique.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507294573052821505, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'informed consent', 'Definition' => 'A process to ensure that patient volunteers understand all the risks associated participating in a clinical trial such as adverse side effects and are choosing to participate without coercion or pressure from anyone. The principal investigator or his or her associates are required to explain the study carefully and answer all questions of a participant before the clinical trial.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Creation User' => 'John Martin', 'Creation Date' => '2011/5/16', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'informed_consent_₇', ))

English (EN)informed consent

A process to ensure that patient volunteers understand all the risks associated participating in a clinical trial such as adverse side effects and are choosing to participate without coercion or pressure from anyone. The principal investigator or his or her ...

French (FR)Consentement éclairé

Un processus afin de s'assurer que les patients volontaires comprennent tous les risques associés à la participation à un essai clinique tels que les effets indésirables et choisissent de participer sans coercition ni pression de quiconque. Le chercheur ...

Pharmaceutical; Clinical trials
stdClass::__set_state(array( 'id' => '6228620', 'url' => 'FR/primary_outcome_measure', 'image' => '', 'title' => 'Critère de jugement principal', 'tags' => array ( 0 => 'Critère de jugement principal', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Critère de jugement principal', 'source_id' => 4011188, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150727104701', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Le critère de jugement défini dans le protocole qui est le plus important pour évaluer l\'effet d\'une intervention. La plupart des études cliniques ont un critère de jugement principal, mais certaines peuvent en avoir plusieurs.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507846081752334336, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'The planned outcome measure in the protocol that is the most important for evaluating the effect of an intervention. Most clinical studies have one primary outcome measure, but some may have more than one.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'primary outcome measure', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'primary_outcome_measure', ))

English (EN)primary outcome measure

The planned outcome measure in the protocol that is the most important for evaluating the effect of an intervention. Most clinical studies have one primary outcome measure, but some may have more than one.

French (FR)Critère de jugement principal

Le critère de jugement défini dans le protocole qui est le plus important pour évaluer l'effet d'une intervention. La plupart des études cliniques ont un critère de jugement principal, mais certaines peuvent en avoir plusieurs.

Medical devices; Clinical trials
stdClass::__set_state(array( 'id' => '6877605', 'url' => 'FR/Angiotensin_II_Receptor_Blockers_(ARBs)', 'image' => '', 'title' => 'Antagonistes des récepteurs de l\'angiotensine II (ARA II)', 'tags' => array ( 0 => 'Antagonistes des récepteurs de l\'angiotensine II (ARA II)', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'Antagonistes des récepteurs de l\'angiotensine II (ARA II)', 'source_id' => 1038764, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20150721084107', 'part_of_speech' => 'proper noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Médicaments qui bloquent l\'action de l\'angiotensine II en l\'empêchant de se lier à des récepteurs de l\'angiotensine II sur les vaisseaux sanguins.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507294573051772930, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Term' => 'Angiotensin II Receptor Blockers (ARBs)', 'Definition' => 'Medications that block the action of angiotensin II by preventing angiotensin II from binding to angiotensin II receptors on blood vessels.', 'Part of Speech' => 'proper noun', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Creation User' => 'CCTRADUCTION', 'Creation Date' => '2011/4/12', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Angiotensin_II_Receptor_Blockers_(ARBs)', ))

English (EN)Angiotensin II Receptor Blockers (ARBs)

Medications that block the action of angiotensin II by preventing angiotensin II from binding to angiotensin II receptors on blood vessels.

French (FR)Antagonistes des récepteurs de l'angiotensine II (ARA II)

Médicaments qui bloquent l'action de l'angiotensine II en l'empêchant de se lier à des récepteurs de l'angiotensine II sur les vaisseaux sanguins.

Pharmaceutical; Drugs
stdClass::__set_state(array( 'id' => '6228624', 'url' => 'FR/Food_And_Drug_Administration_(FDA)', 'image' => '', 'title' => 'Food And Drug Administration (FDA)', 'tags' => array ( 0 => 'Food And Drug Administration (FDA)', 1 => 'Medical devices', 2 => 'Pharmaceutical', 3 => 'Clinical trials', 4 => 'National Library of Medicine', 5 => '', ), 'term' => 'Food And Drug Administration (FDA)', 'source_id' => 4011189, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Medical devices', 1 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'company' => array ( 0 => 'National Library of Medicine', ), 'lastedit' => '20150727104702', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Une agence du Département de la Santé et des Services sociaux des États-Unis. La FDA est responsable de la protection de la santé publique. Elle se doit d\'assurer la sureté, l\'efficacité et la sécurité des médicaments humains et vétérinaires, des vaccins et autres produits biologiques, des dispositifs médicaux, de l\'approvisionnement alimentaire de la nation, des cosmétiques, des compléments alimentaires et des produits qui émettent des radiations.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507846081753382912, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Company' => 'National Library of Medicine', 'Definition' => 'An agency within the U.S. Department of Health and Human Services. FDA is responsible for protecting the public health by making sure that human and veterinary drugs, vaccines and other biological products, medical devices, the nation\'s food supply, cosmetics, dietary supplements, and products that give off radiation are safe, effective, and secure.', 'Industry' => 'Medical devices; Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Clinical trials', 'Creation User' => 'elighy', 'Creation Date' => '2012/10/13', 'Term' => 'Food And Drug Administration (FDA)', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Food_And_Drug_Administration_(FDA)', ))

English (EN)Food And Drug Administration (FDA)

An agency within the U.S. Department of Health and Human Services. FDA is responsible for protecting the public health by making sure that human and veterinary drugs, vaccines and other biological products, medical devices, the nation's food supply, ...

French (FR)Food And Drug Administration (FDA)

Une agence du Département de la Santé et des Services sociaux des États-Unis. La FDA est responsable de la protection de la santé publique. Elle se doit d'assurer la sureté, l'efficacité et la sécurité des médicaments humains et vétérinaires, des vaccins et ...

Medical devices; Clinical trials
stdClass::__set_state(array( 'id' => '3897820', 'url' => 'FR/variable-interval_₁', 'image' => '', 'title' => 'Intervalle variable', 'tags' => array ( 0 => 'Intervalle variable', 1 => 'Pharmaceutical', 2 => 'Pharmaceutical intermediates', 3 => '', ), 'term' => 'Intervalle variable', 'source_id' => 3744241, 'type' => 'term', 'namespace' => 1244, 'nstext' => 'FR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Pharmaceutical intermediates', ), 'lastedit' => '20150722105901', 'part_of_speech' => 'noun', 'creation_user' => 'LinguaDiligence', 'special_term' => '', 'definition' => 'Un renforçateur dépend de la première réponse après un intervalle de temps variable depuis la dernière opportunité pour un renforcement.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1507393851727282176, 'nstext_full' => 'French (FR)', 's_attr' => stdClass::__set_state(array( 'Definition' => 'A reinforcer is contingent on the first response after a variable interval of time since the last opportunity for reinforcement.', 'Domain' => 'Documentation', 'Industry' => 'Pharmaceutical', 'Part of Speech' => 'noun', 'Product Category' => 'Pharmaceutical intermediates', 'Usage Status' => 'New', 'Creation User' => 'lovinbnsingle', 'Creation Date' => '2012/9/5', 'Glossary' => 'MODULE_3_twgid1346807673617222', 'Term' => 'variable-interval', 'Source Lang' => '1180', )), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'variable-interval_₁', ))

English (EN)variable-interval

A reinforcer is contingent on the first response after a variable interval of time since the last opportunity for reinforcement.

French (FR)Intervalle variable

Un renforçateur dépend de la première réponse après un intervalle de temps variable depuis la dernière opportunité pour un renforcement.

Pharmaceutical; Pharmaceutical intermediates